COMMONWEALTH EQUITY SERVICES, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6
-89.8%
48,638
-58.2%
0.00%
Q2 2023$59
-19.2%
116,367
-0.7%
0.00%
Q1 2023$73
-2.7%
117,244
+1.3%
0.00%
Q4 2022$75
-100.0%
115,744
-9.6%
0.00%
-100.0%
Q3 2022$220,000
+39.2%
128,0660.0%0.00%
Q2 2022$158,000
+59.6%
128,066
-15.9%
0.00%
Q1 2022$99,000
-42.4%
152,344
-3.9%
0.00%
Q4 2021$172,000
-35.8%
158,594
+7.4%
0.00%
-100.0%
Q3 2021$268,000
+53.1%
147,666
+122.7%
0.00%
Q2 2021$175,000
+8.0%
66,293
+46.6%
0.00%
Q1 2021$162,000
-3.0%
45,218
-32.0%
0.00%
-100.0%
Q4 2020$167,000
+42.7%
66,521
+42.8%
0.00%
Q3 2020$117,000
-14.0%
46,571
+12.3%
0.00%
-100.0%
Q2 2020$136,000
+30.8%
41,471
-2.4%
0.00%
Q1 2020$104,000
-48.3%
42,471
-0.7%
0.00%
-100.0%
Q4 2019$201,000
-4.3%
42,750
-13.1%
0.00%0.0%
Q3 2019$210,000
-32.0%
49,194
-7.3%
0.00%0.0%
Q2 2019$309,000
+39.2%
53,094
-7.9%
0.00%0.0%
Q1 2019$222,000
+86.6%
57,669
-9.4%
0.00%0.0%
Q4 2018$119,000
-42.0%
63,649
-0.8%
0.00%0.0%
Q3 2018$205,000
+9.0%
64,146
+2.9%
0.00%0.0%
Q2 2018$188,000
-16.8%
62,316
+7.9%
0.00%0.0%
Q1 2018$226,000
-5.4%
57,776
+0.0%
0.00%0.0%
Q4 2017$239,00057,7560.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders